Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Subject Recruitment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Measurement of cytokine levels in post-cardiac transplant patients with unexplained graft dysfunction.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group 1 | Heart Transplant Recipients with Unexplained Graft Dysfunction | ||
| Group 2 | Normal Control | ||
| Group 3 | Class III-IV Heart Failure | ||
| Group 4 | Heart Transplant Recipients with Normal Graft Function |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Differences in cytokine profiles between stable heart transplant recipients and those with acute rejection | Differences in cytokine profiles between stable heart transplant recipients and those with acute rejection | 12 months |
Not provided
Not provided
Inclusion Criteria:
Group 1
Group 2
Exclusion Criteria:
Group 1 Heart Transplant with Unexplained Graft Dysfunction
Group 2 Normal Control group
Group 3 Heart Failure Group
Group 4 Heart Transplant with Normal Graft Function Group
Not provided
Not provided
Not provided
Cardiology Clinic and inpatient service. Normal controls are volunteers from within the community.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Peter M Eckman, MD | University of Minnesota | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided